Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003733322 | SCV004525047 | uncertain significance | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 34 of the MCM2 protein (p.Arg34Pro). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with MCM2-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004636831 | SCV005132528 | uncertain significance | not specified | 2024-05-21 | criteria provided, single submitter | clinical testing | The c.101G>C (p.R34P) alteration is located in exon 2 (coding exon 2) of the MCM2 gene. This alteration results from a G to C substitution at nucleotide position 101, causing the arginine (R) at amino acid position 34 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |